LATAM Cargo, the cargo of the LATAM Group, recorded a 40% growth in the volume of tons of pharmaceutical products transported from Europe to Brazil between January and March 2025, when compared to the same period in 2024. There were 860 tons of pharmaceutical cargo transported in the first quarter of this year, compared to 613 tons in the same period last year. The airports of Guarulhos (São Paulo), Curitiba (Paraná) and Viracopos (Campinas) lead the ranking of destinations that received the most this type of cargo in Brazil, coming especially from Frankfurt (), Copenhagen (Denmark) and Brussels (Belgium).
Today, the LATAM group positions itself as a leader in the transportation of pharmaceutical products thanks to its specialized Pharma product, its state-of-the-art handling facilities and its flexibility to offer customized flights to specific destinations.
COLD CHAIN
LATAM has made significant investments in quality control and continuous improvement by closely monitoring its cold chain processes through proprietary tracking devices. By leveraging this data, the airline has been able to identify potential weaknesses in the cold chain and quickly implement corrective actions and best practices to ensure the integrity and safety of pharmaceutical shipments. This has enabled the LATAM group to expand its PHARMA network by 50% in recent years, with an increase of nearly 40% in the kilos of pharmaceutical products transported from Europe compared to 2023.
Additionally, LATAM Cargo Group recently received CEIV Pharma recertification from the Center of Excellence for Independent Validators (CEIV) of the International Air Transport Association (IATA). The company was the first airline in the Americas to obtain this certification in 2017, which reinforces its commitment to maintaining the highest standards in pharmaceutical transportation, ensuring continuous improvement and a solid operational structure for cargo handling and management.